Skip to content
10-Q

Quarterly Report

Todos Medical Ltd.

0001493152-21-028721

← back to feed
Filed
Nov 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 11, 2021 914.39M sh
Shares Diluted Q3 2021 · Sep 30, 2021 637.92B sh
Shares Diluted Q3 2021 · Sep 30, 2020 210.81B sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $166K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $935K
Stockholders Equity Q3 2021 · Sep 30, 2021 −$10.5M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$9M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$19.46M
Stockholders Equity Q3 2021 · Dec 31, 2020 −$11.01M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$8.37M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$4.65M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$6.26M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$6.25M
Current Liabilities Q3 2021 · Sep 30, 2021 $8.19M
Current Liabilities Q3 2021 · Dec 31, 2020 $8.07M
Current Assets Q3 2021 · Sep 30, 2021 $4.27M
Current Assets Q3 2021 · Dec 31, 2020 $2.45M
Total Assets Q3 2021 · Sep 30, 2021 $17.16M
Total Assets Q3 2021 · Dec 31, 2020 $6.01M
Stock Repurchased Q3 2021 · Jul 2, 2021 $1.17M
Net Income Q3 2021 · Jun 30, 2021 $3.39M
Net Income Q3 2021 · Mar 31, 2021 −$17.56M
Net Income Q3 2021 · Sep 30, 2020 −$18.04M
Net Income Q3 2021 · Sep 30, 2020 −$25.26M
Net Income Q3 2021 · Jun 30, 2020 −$2.59M
Net Income Q3 2021 · Mar 31, 2020 −$4.64M
Capex Q3 2021 · Sep 30, 2020 $346K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$3.67M
Sga Expense Q3 2021 · Sep 30, 2020 $804K
Sga Expense Q3 2021 · Sep 30, 2020 $1.73M
Operating Income Q3 2021 · Sep 30, 2020 −$10.25M
Operating Income Q3 2021 · Sep 30, 2020 −$13.15M
Gross Profit Q3 2021 · Sep 30, 2020 $401K
Gross Profit Q3 2021 · Sep 30, 2020 $422K
Cost Of Revenue Q3 2021 · Sep 30, 2020 $883K
Cost Of Revenue Q3 2021 · Sep 30, 2020 $894K
Revenue Q3 2021 · Sep 30, 2020 $1.28M
Revenue Q3 2021 · Sep 30, 2020 $1.32M